186 related articles for article (PubMed ID: 22970150)
1. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial.
Mangalat N; Liu Y; Fatheree NY; Ferris MJ; Van Arsdall MR; Chen Z; Rahbar MH; Gleason WA; Norori J; Tran DQ; Rhoads JM
PLoS One; 2012; 7(9):e43910. PubMed ID: 22970150
[TBL] [Abstract][Full Text] [Related]
2. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
Savino F; Garro M; Montanari P; Galliano I; Bergallo M
J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Fatheree NY; Liu Y; Taylor CM; Hoang TK; Cai C; Rahbar MH; Hessabi M; Ferris M; McMurtry V; Wong C; Vu T; Dancsak T; Wang T; Gleason W; Bandla V; Navarro F; Tran DQ; Rhoads JM
J Pediatr; 2017 Dec; 191():170-178.e2. PubMed ID: 28969890
[TBL] [Abstract][Full Text] [Related]
4. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
5. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
Sung V; Hiscock H; Tang ML; Mensah FK; Nation ML; Satzke C; Heine RG; Stock A; Barr RG; Wake M
BMJ; 2014 Apr; 348():g2107. PubMed ID: 24690625
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study.
Jones ML; Martoni CJ; Tamber S; Parent M; Prakash S
Food Chem Toxicol; 2012 Jun; 50(6):2216-23. PubMed ID: 22425689
[TBL] [Abstract][Full Text] [Related]
7. Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention.
Szymanski H; Mlynarz P; Qasem B; Korzeniowska-Kowal A; Szponar B; Kałwak-Baran M; Szajewska H
Acta Biochim Pol; 2020 Sep; 67(3):393-399. PubMed ID: 32945647
[TBL] [Abstract][Full Text] [Related]
8. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri ATCC55730 in cystic fibrosis.
Di Nardo G; Oliva S; Menichella A; Pistelli R; De Biase RV; Patriarchi F; Cucchiara S; Stronati L
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):81-6. PubMed ID: 24121143
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with
Savino F; Galliano I; Garro M; Savino A; Daprà V; Montanari P; Bergallo M
Benef Microbes; 2018 Dec; 9(6):917-925. PubMed ID: 30406696
[TBL] [Abstract][Full Text] [Related]
13. Limosilactobacillus reuteri DSM-17938 for preventing cough in adults with mild allergic asthma: A double-blind randomized placebo-controlled cross-over study.
Satia I; Cusack R; Stevens C; Schlatman A; Wattie J; Mian F; Killian KJ; O'Byrne PM; Bienenstock J; Forsythe P; Gauvreau GM
Clin Exp Allergy; 2021 Sep; 51(9):1133-1143. PubMed ID: 34192396
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
15. Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis.
Ojetti V; Saviano A; Brigida M; Petruzziello C; Caronna M; Gayani G; Franceschi F
Eur J Gastroenterol Hepatol; 2022 May; 34(5):496-502. PubMed ID: 35045564
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial.
Jones ML; Martoni CJ; Di Pietro E; Simon RR; Prakash S
Regul Toxicol Pharmacol; 2012 Jul; 63(2):313-20. PubMed ID: 22561556
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Supplementation in Preterm: Feeding Intolerance and Hospital Cost.
Indrio F; Riezzo G; Tafuri S; Ficarella M; Carlucci B; Bisceglia M; Polimeno L; Francavilla R
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28858247
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.
Chau K; Lau E; Greenberg S; Jacobson S; Yazdani-Brojeni P; Verma N; Koren G
J Pediatr; 2015 Jan; 166(1):74-8. PubMed ID: 25444531
[TBL] [Abstract][Full Text] [Related]
19.
García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial.
Savino F; Cordisco L; Tarasco V; Palumeri E; Calabrese R; Oggero R; Roos S; Matteuzzi D
Pediatrics; 2010 Sep; 126(3):e526-33. PubMed ID: 20713478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
